JPH0662680B2 - Method for producing carrier for immobilizing antibody - Google Patents
Method for producing carrier for immobilizing antibodyInfo
- Publication number
- JPH0662680B2 JPH0662680B2 JP62315734A JP31573487A JPH0662680B2 JP H0662680 B2 JPH0662680 B2 JP H0662680B2 JP 62315734 A JP62315734 A JP 62315734A JP 31573487 A JP31573487 A JP 31573487A JP H0662680 B2 JPH0662680 B2 JP H0662680B2
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- carrier
- chitosan
- immobilized
- μmol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 230000003100 immobilizing effect Effects 0.000 title claims description 6
- 238000004519 manufacturing process Methods 0.000 title claims description 3
- 229920001661 Chitosan Polymers 0.000 claims description 26
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 claims description 24
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 claims description 7
- FALRKNHUBBKYCC-UHFFFAOYSA-N 2-(chloromethyl)pyridine-3-carbonitrile Chemical compound ClCC1=NC=CC=C1C#N FALRKNHUBBKYCC-UHFFFAOYSA-N 0.000 claims description 6
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 claims description 6
- 229940014800 succinic anhydride Drugs 0.000 claims description 6
- 230000000397 acetylating effect Effects 0.000 claims 1
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 20
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 14
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 12
- 239000008187 granular material Substances 0.000 description 12
- 239000000243 solution Substances 0.000 description 11
- 239000000203 mixture Substances 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 8
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 7
- 239000007864 aqueous solution Substances 0.000 description 7
- 230000007935 neutral effect Effects 0.000 description 7
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 6
- 230000000694 effects Effects 0.000 description 5
- 102000010445 Lactoferrin Human genes 0.000 description 4
- 108010063045 Lactoferrin Proteins 0.000 description 4
- 125000003277 amino group Chemical group 0.000 description 4
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 description 4
- 229940078795 lactoferrin Drugs 0.000 description 4
- 235000021242 lactoferrin Nutrition 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 239000008363 phosphate buffer Substances 0.000 description 4
- 239000002798 polar solvent Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 230000002378 acidificating effect Effects 0.000 description 3
- 239000013543 active substance Substances 0.000 description 3
- 238000001042 affinity chromatography Methods 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 230000000356 anti-lactoferrin effect Effects 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 230000000890 antigenic effect Effects 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 150000001718 carbodiimides Chemical class 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- JXTHNDFMNIQAHM-UHFFFAOYSA-N dichloroacetic acid Chemical compound OC(=O)C(Cl)Cl JXTHNDFMNIQAHM-UHFFFAOYSA-N 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 239000012085 test solution Substances 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- PMUNIMVZCACZBB-UHFFFAOYSA-N 2-hydroxyethylazanium;chloride Chemical compound Cl.NCCO PMUNIMVZCACZBB-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- 238000004438 BET method Methods 0.000 description 1
- ZNZYKNKBJPZETN-WELNAUFTSA-N Dialdehyde 11678 Chemical compound N1C2=CC=CC=C2C2=C1[C@H](C[C@H](/C(=C/O)C(=O)OC)[C@@H](C=C)C=O)NCC2 ZNZYKNKBJPZETN-WELNAUFTSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
- 239000008351 acetate buffer Substances 0.000 description 1
- 230000021736 acetylation Effects 0.000 description 1
- 238000006640 acetylation reaction Methods 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 230000006196 deacetylation Effects 0.000 description 1
- 238000003381 deacetylation reaction Methods 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 229960005215 dichloroacetic acid Drugs 0.000 description 1
- -1 diisocyanate compound Chemical class 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N hydrochloric acid Substances Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- CEQFOVLGLXCDCX-WUKNDPDISA-N methyl red Chemical compound C1=CC(N(C)C)=CC=C1\N=N\C1=CC=CC=C1C(O)=O CEQFOVLGLXCDCX-WUKNDPDISA-N 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000013076 target substance Substances 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- Peptides Or Proteins (AREA)
Description
【発明の詳細な説明】 [産業上の利用分野] 本発明は、抗体を固定化し抗体活性を最大限に発揮し、
目的とする抗原物質を効率よく分離精製する、例えばア
フィニティクロマトグラフィー等の用途に好適な抗体の
製造法に関する。DETAILED DESCRIPTION OF THE INVENTION [Industrial field of application] The present invention immobilizes antibodies to maximize antibody activity,
The present invention relates to a method for producing an antibody, which is suitable for applications such as affinity chromatography, for efficiently separating and purifying a target antigenic substance.
[従来の技術] 従来、キトサンを用いて抗体を固定化させるために、キ
トサンのアミノ基を利用してグルタールアルデヒド等の
ジアルデヒドを用いることはよく知られている。又、カ
ルボジイミド試薬でペプチド結合として利用することも
特公昭53−10150号に開示されている。本発明者等は、
先に特願昭62−92623号においてカルボキシル基を有す
る多孔質粒状キトサン誘導体をジシクロヘキシルカルボ
ジイミドとN-ヒドロキシコハク酸イミドで処理して生理
活性物質固定化用担体を得る方法を提案している。[Prior Art] It has been well known that a dialdehyde such as glutaraldehyde is used by utilizing an amino group of chitosan in order to immobilize an antibody using chitosan. The use of a carbodiimide reagent as a peptide bond is also disclosed in Japanese Patent Publication No. 53-10150. The present inventors
Japanese Patent Application No. 62-92623 has previously proposed a method for obtaining a carrier for immobilizing a physiologically active substance by treating a porous granular chitosan derivative having a carboxyl group with dicyclohexylcarbodiimide and N-hydroxysuccinimide.
[発明が解決しようとする問題点] 上述の、本発明者等が先に出願したカルボキシル基を有
する多孔質粒状キトサン誘導体を、ジシクロヘキシルカ
ルボジイミドとN-ヒドロキシコハク酸イミドで処理した
方法による担体は、酵素等の生理活性物質を変性させず
に容易に固定化でき、固定化後の非特異的な吸着もない
ために有効に利用することは出来る。しかし、抗体の如
き分子量が15万を超える物質を固定化するときに、固定
化された抗体同志が立体障害を生じ抗体活性が充分発揮
出来ない欠点がある。それは固定化する生理活性物質の
密度を制御出来ないからである。従って、抗体の反応部
位が抗原と有効に反応出来るように露出する形で固定化
されないために、抗体固定化担体を使って分離しようと
する抗原物質の回収量が著しく低下してしまう。[Problems to be Solved by the Invention] The carrier prepared by treating the above-mentioned porous granular chitosan derivative having a carboxyl group previously filed by the present inventors with dicyclohexylcarbodiimide and N-hydroxysuccinimide is A physiologically active substance such as an enzyme can be easily immobilized without denaturation, and non-specific adsorption after immobilization does not occur, so that it can be effectively used. However, when a substance such as an antibody having a molecular weight of more than 150,000 is immobilized, the immobilized antibodies are sterically hindered and the antibody activity cannot be sufficiently exhibited. This is because the density of the immobilized physiologically active substance cannot be controlled. Therefore, the reaction site of the antibody is not immobilized in an exposed form so that it can effectively react with the antigen, so that the recovery amount of the antigenic substance to be separated using the antibody-immobilized carrier is significantly reduced.
本発明は、上述の欠点を解決し、抗体同志の立体障害を
生じない様に活性基の導入量を制御することにより、良
好な抗体固定化用担体を得ることを目的とする。An object of the present invention is to solve the above-mentioned drawbacks and to obtain a good carrier for antibody immobilization by controlling the introduction amount of the active group so as not to cause steric hindrance between the antibodies.
[問題点を解決するための手段] 本発明は、粒状多孔質キトサンを無水酢酸で部分アセチ
ル化した後、無水コハク酸で処理し、無水酢酸量で交換
容量の制御を計り、更にジシクロヘキシルカルボジイミ
ドとN-ヒドロキシスクシンイミドで処理して抗体固定化
用担体を得るものである。[Means for Solving Problems] In the present invention, granular porous chitosan is partially acetylated with acetic anhydride, then treated with succinic anhydride, and the exchange capacity is controlled by the amount of acetic anhydride. The carrier for antibody immobilization is obtained by treating with N-hydroxysuccinimide.
本発明に用いられる粒状多孔質キトサンは、先に特開昭
61−40337号で開示した方法により得ることが出来る。
本発明に用いるキトサンは特に限定されないが、平均分
子量10,000〜230,000の低分子量キトサンを用いること
が好ましい。キトサンを酢酸,ジクロロ酢酸、蟻酸等の
単独若しくは混合物の水溶液に溶解してキトサン酸性水
溶液を得る。該キトサン酸性水溶液の濃度は、2〜20%
が好ましい。該キトサン酸性水溶液は水酸化ナトリウ
ム,水酸化カリウム,炭酸ナトリウム,炭酸カリウム,
アンモニア,エチレンジアミン等のアルカリ性物質を含
む塩基性の水溶液中に、吐出孔より圧力下で一定量づつ
落下させ凝固再生させ、中性になる迄充分水洗を行って
粒状多孔質キトサンを得る。この時、塩基性水溶液にア
ルコール等の極性溶媒を併用することも出来、必要に応
じて粒状多孔質キトサンを更に極性溶媒中で有機ジイソ
シアネート化合物等で架橋処理を行ってもよい。The granular porous chitosan used in the present invention was previously disclosed in
It can be obtained by the method disclosed in 61-40337.
The chitosan used in the present invention is not particularly limited, but it is preferable to use low molecular weight chitosan having an average molecular weight of 10,000 to 230,000. Chitosan is dissolved in an aqueous solution of acetic acid, dichloroacetic acid, formic acid or the like alone or in a mixture to obtain an acidic aqueous chitosan solution. The concentration of the chitosan acidic aqueous solution is 2 to 20%
Is preferred. The chitosan acidic aqueous solution is sodium hydroxide, potassium hydroxide, sodium carbonate, potassium carbonate,
A granular aqueous chitosan is obtained by dropping it into a basic aqueous solution containing an alkaline substance such as ammonia or ethylenediamine under pressure from the discharge hole at a fixed amount to coagulate and regenerate it, and sufficiently wash it until it becomes neutral. At this time, a polar solvent such as alcohol may be used in combination with the basic aqueous solution, and if necessary, the granular porous chitosan may be subjected to a crosslinking treatment with an organic diisocyanate compound or the like in a polar solvent.
上述の如くして得た粒状多孔質キトサンを無水酢酸で処
理してアセチル化を行うが、無水酢酸の量を調節してア
ミノ基の密度を制御し、無水コハク酸でカルボキシル基
を導入し所望の活性基の導入を計る。その後、中性にな
る迄充分水洗を行う。この時の活性基の導入量は、好ま
しくは5〜140μmol/ml粒状体である。活性基の密度が
5μmol/ml粒状体以下では固定化される抗体量が少く、
容量のみが大きくなり不利で、一方140μmol/ml粒状体
以上では固定化された抗体に立体障害が生じ、抗体の活
性が充分有効に発揮されない欠点を生ずる。The granular porous chitosan obtained as described above is treated with acetic anhydride for acetylation. The amount of acetic anhydride is adjusted to control the density of amino groups, and the desired carboxyl group is introduced with succinic anhydride. Measure the introduction of active groups. After that, wash thoroughly with water until neutral. The amount of the active group introduced at this time is preferably 5 to 140 μmol / ml granular material. When the density of active groups is 5 μmol / ml or less, the amount of immobilized antibody is small,
This is disadvantageous in that only the capacity becomes large. On the other hand, above 140 μmol / ml granules cause steric hindrance to the immobilized antibody, resulting in a drawback that the antibody activity is not sufficiently exhibited.
上述の如くして得られたカルボキシル基を導入した粒状
多孔質キトサンを、極性溶媒である例えばジオキサン,
ジメチルホルムアミド,ジメチルアセトアミド,ジメチ
ルスルホオキシド,テトラヒドロフラン等に懸濁させた
後にジシクロヘキシルカルボジイミド等のカルボジイミ
ド等の結合剤とN-ヒドロキシスクシンイミドを加え、室
温で役24時間攪拌反応させる。反応終了後、使用した極
性溶媒で充分洗浄することにより優れた抗体固定化用担
体が得られる。The granular porous chitosan introduced with a carboxyl group obtained as described above is treated with a polar solvent such as dioxane,
After suspending in dimethylformamide, dimethylacetamide, dimethylsulfoxide, tetrahydrofuran or the like, a binder such as carbodiimide such as dicyclohexylcarbodiimide and N-hydroxysuccinimide are added, and the mixture is stirred and reacted at room temperature for 24 hours. After completion of the reaction, an excellent carrier for antibody immobilization can be obtained by thorough washing with the polar solvent used.
本発明の抗体固定化用担体に用いられる抗体としては、
アフィニティ−クロマトグラフィーによって精製しよう
とする目的物を抗原とするすべてのモノクローナル,ポ
リクローナル抗体が使用出来る。The antibody used for the antibody-immobilizing carrier of the present invention includes
All monoclonal and polyclonal antibodies whose antigens are the target substances to be purified by affinity chromatography can be used.
[実施例] 以下、本発明を実施例により説明するが、本発明は実施
例記載の範囲に限定されるものではない。[Examples] Hereinafter, the present invention will be described with reference to Examples, but the present invention is not limited to the scope of the Examples.
尚、活性基密度及び比表面積は下記の方法により求め
た。The active group density and the specific surface area were determined by the following methods.
(A)活性基密度 試料約50mlを1N−HCl 500ml中でゆるやかに攪拌しなが
ら、1時間処理し、脱イオン水で中性になる迄充分洗浄
し、空気中の炭酸ガスを吸収させない様に注意しながら
脱水した試料30mlを正確に迅速に計りとり、1/5N−NaOH
500ml中に投入し、ゆるやかに攪拌しながら5時間放置
する。この上澄液を試験液とする。これを10ml搾取し、
メチルレッド溶液を指示薬として1/10N−HClで中和滴定
し次式で求めた。(A) Active group density Approximately 50 ml of sample is treated in 500 ml of 1N-HCl with gentle stirring for 1 hour and washed thoroughly with deionized water until it becomes neutral so that carbon dioxide gas in the air is not absorbed. Accurately and quickly weigh 30 ml of the dehydrated sample carefully, and use 1/5 N-NaOH
Add to 500 ml and leave for 5 hours with gentle stirring. This supernatant is used as a test solution. Exploit 10 ml of this,
The methyl red solution was used as an indicator and was neutralized and titrated with 1/10 N-HCl to obtain the value by the following formula.
a:試験液10mlを中和するに要した1/10 N−HCl 量 b:試料を入れる前の1/5N−NaOH 10mlを中和する のに要した1/10 N−HCl量 f:1/10 N−HClの力価 (B)比表面積 比表面積測定装置を用いてBET 法で測定した。 a: Amount of 1/10 N-HCl required to neutralize 10 ml of the test solution b: Amount of 1/10 N-HCl required to neutralize 10 ml of 1/5 N-NaOH before adding the sample f: 1 / 10 N-HCl titer (B) Specific surface area BET method was used to measure the specific surface area.
実施例 脱アセチル化度77%,平均分子量42,000のキトサン65g
を3.25%酢酸水溶液935gに溶解し、該溶液を7%の水
酸化ナトリウム,30%のエタノール,63%の水からなる
混合溶液中に、0.15mmφの孔径ノズルから落下させ、凝
固再生させた後、中性になるまで水洗し、平均粒径0.3m
mφの粒状多孔質キトサン0.9を得た。Example 65 g of chitosan having a deacetylation degree of 77% and an average molecular weight of 42,000
Was dissolved in 935 g of a 3.25% acetic acid aqueous solution, and the solution was dropped into a mixed solution of 7% sodium hydroxide, 30% ethanol and 63% water from a nozzle having a hole diameter of 0.15 mm and coagulated and regenerated. , Washed with water until neutral, average particle size 0.3m
A mφ granular porous chitosan 0.9 was obtained.
得られた粒状多孔質キトサン夫々100ml(湿潤状態)を1
00mlのエタノールで4回置換し水を除去した。そして夫
々にエタノール100mlを加えて無水酢酸1.9g,2.6g,
4.0g,6.4g,10.0g,12.8gを加え室温で24時間反応
させた。その後、1N-水酸化ナトリウム100mlを加え、1
時間攪拌後中性になる迄充分水洗し、再び100mlのエタ
ノールで4回置換した後エタノール100ml,無水コハク
酸10gを加え、室温で24時間反応させた。1N-水酸化ナ
トリウム100mlで処理後、1N-塩酸100mlを加え1時間攪
拌、中性になる迄充分水洗した。得られたキトサン粒状
体の活性基密度を測定したところ、夫々140μmol/ml粒
状体,66μmol/ml粒状体,55μmol/ml粒状体,37μmol/
ml粒状体,25μmol/ml粒状体,15μmol/ml粒状体であっ
た。100 ml (wet state) of each of the obtained granular porous chitosan
The mixture was replaced with 00 ml of ethanol four times to remove water. Then, add 100 ml of ethanol to each, and add 1.9 g and 2.6 g of acetic anhydride.
4.0 g, 6.4 g, 10.0 g and 12.8 g were added and the reaction was carried out at room temperature for 24 hours. Then, add 100 ml of 1N-sodium hydroxide and add 1
After stirring for a period of time, the mixture was thoroughly washed with water until it became neutral, replaced with 100 ml of ethanol 4 times again, 100 ml of ethanol and 10 g of succinic anhydride were added, and the mixture was reacted at room temperature for 24 hours. After treatment with 100 ml of 1N-sodium hydroxide, 100 ml of 1N-hydrochloric acid was added, and the mixture was stirred for 1 hour and washed thoroughly with water until neutral. The active group densities of the obtained chitosan granules were measured and found to be 140 μmol / ml granules, 66 μmol / ml granules, 55 μmol / ml granules, 37 μmol / ml, respectively.
They were ml granules, 25 μmol / ml granules, and 15 μmol / ml granules.
続いて上記の6試料について、夫々をジオキサン100ml
で2回置換後、ジオキサン100mlを加え、ジシクロヘキ
シルカルボジイミド5.0gとN-ヒドロキシスクシンイミ
ド2.5gを加え室温で24時間攪拌した。その後ジオキサ
ン100mlで2回,メタノール100mlで2回,ジオキサン10
0mlで2回,イソプロピルアルコールで2回洗浄して各
試料につき抗体固定化用担体を夫々80ml得た。夫々の比
表面積を測定したところ69.0m2/g,73.0m2/g,85.0
m2/g,63.3m2/g,91.5m2/g,80.5m2/gであっ
た。Then, 100 ml of dioxane was added to each of the above 6 samples.
After replacement with twice with 100 ml of dioxane, 5.0 g of dicyclohexylcarbodiimide and 2.5 g of N-hydroxysuccinimide were added, and the mixture was stirred at room temperature for 24 hours. Then 100 ml of dioxane twice, 100 ml of methanol twice, dioxane 10
The sample was washed twice with 0 ml and twice with isopropyl alcohol to obtain 80 ml of the antibody-immobilizing carrier for each sample. Measurement of the specific surface area of each 69.0m 2 /g,73.0m 2 /g,85.0
was m 2 /g,63.3m 2 /g,91.5m 2 /g,80.5m 2 / g.
応用例 上記実施例で得た活性基密度15μmol/ml粒状体のものか
ら得た抗体固定化用担体であって、イソプロピルアルコ
ール中に保存した3mlを採取し、イソプロピルアルコー
ルを遠心分離して除去し、純水で洗浄した。直ちに0.3M
塩化ナトリウムを含む0.2M炭酸水素ナトリウムに溶解さ
せた7mg/mlのモノクローナル抗ラクトフェリン抗体溶
液6mlを加え、4℃で一晩緩かに攪拌した。そして遠心
分離により未反応の抗体溶液を除いた後、0.2Mエタノー
ルアミン−塩酸溶液(pH8)で2回繰返し洗浄し、同溶液6
mlを加えて4℃で2時間攪拌し、リン酸緩衝液で洗浄し
た後抗体固定化担体を得た。固定化された抗体量を反応
前後の蛋白質濃度から求めたところ、7.4mg抗体/ml担
体で良好な固定化量であった。これを4℃で保有し、得
られた抗体固定化担体3mlを直径1cm,長さ5cmのカラム
に充填し、0.15M塩化ナトリウムを含む0.02Mリン酸緩衝
液(pH7.2)で充分洗浄後、上述のリン酸緩衝液に溶解さ
せた0.1%ラクトフェリン溶液20mlを流速2ml/minで流
した。Application Example A carrier for antibody immobilization obtained from those having an active group density of 15 μmol / ml granules obtained in the above Example, 3 ml stored in isopropyl alcohol was collected, and isopropyl alcohol was removed by centrifugation. It was washed with pure water. 0.3M immediately
6 ml of a 7 mg / ml monoclonal anti-lactoferrin antibody solution dissolved in 0.2 M sodium hydrogen carbonate containing sodium chloride was added, and the mixture was gently stirred overnight at 4 ° C. Then, after removing unreacted antibody solution by centrifugation, it was repeatedly washed twice with 0.2 M ethanolamine-hydrochloric acid solution (pH 8), and the same solution 6
After adding ml, the mixture was stirred at 4 ° C. for 2 hours and washed with a phosphate buffer to obtain an antibody-immobilized carrier. When the amount of immobilized antibody was determined from the protein concentration before and after the reaction, the amount immobilized was 7.4 mg antibody / ml carrier. Hold this at 4 ° C, fill 3 ml of the obtained antibody-immobilized carrier into a column with a diameter of 1 cm and a length of 5 cm, and wash thoroughly with 0.02 M phosphate buffer (pH 7.2) containing 0.15 M sodium chloride. 20 ml of a 0.1% lactoferrin solution dissolved in the above-mentioned phosphate buffer was flowed at a flow rate of 2 ml / min.
上述のリン酸緩衝液で担体を充分洗浄し、0.15M塩化ナ
トリウムを含む0.2M酢酸緩衝液(pH3.5)で、吸着させた
ラクトフェリンを溶出させた。回収ラクトフェリン溶液
の容量を直ちに計り、又、蛋白質濃度を蛋白質測定キッ
ト(Bio Rad社製)で測定したところ、8.4mgのラクトン
が回収されていた。固定化されている抗体量で、回収さ
れたラクトフェリン量を除した値を反応率とすれば(8.4
/7.4×3)×100=37.9%であった。同様に活性基密度が
夫々、140μmol/ml担体,66μmol/ml担体,55μmol/ml
担体,37μmol/ml担体,25μmol/ml担体のものから得た
抗体固定化用担体につき同様の操作を行い反応率を求め
たところ、夫々23%,29%,32%,35%,37%であっ
た。The carrier was thoroughly washed with the above-mentioned phosphate buffer, and the adsorbed lactoferrin was eluted with 0.2 M acetate buffer (pH 3.5) containing 0.15 M sodium chloride. The volume of the recovered lactoferrin solution was immediately measured, and the protein concentration was measured with a protein measurement kit (manufactured by Bio Rad). As a result, 8.4 mg of lactone was recovered. If the reaction rate is calculated by dividing the amount of recovered lactoferrin by the amount of immobilized antibody (8.4
/7.4 x 3) x 100 = 37.9%. Similarly, the active group density is 140μmol / ml carrier, 66μmol / ml carrier, 55μmol / ml
The same procedure was performed for the antibody-immobilized carriers obtained from the carrier, 37 μmol / ml carrier, and 25 μmol / ml carrier, and the reaction rates were determined to be 23%, 29%, 32%, 35%, and 37%, respectively. there were.
比較例 脱アセチル化度77%,平均分子量42,000のキトサン65g
を3.25%酢酸水溶液935gに溶解し、該溶液を7%の水
酸化ナトリウム,30%のエタノール,63%の水からなる
混合溶液中に0.15mmφの孔径ノズルから落下させ凝固再
生させた後、中性になるまで水洗し、平均粒径0.3mmφ
の粒状多孔質キトサン0.9を得た。得られた粒状多孔
質キトサン50ml(湿潤状態)をジメチルホルムアミド50
mlで2回置換洗浄後0.5gのアジピン酸活性エステルを
含むジメチルホルムアミド溶液50mlを加え一晩湿潤させ
た。その後、50mlのジメチルホルムアミドで4回洗浄
し、1.0gの無水コハク酸を加え一晩浸潤させ、メチル
アルコールで4回洗浄しカルボキシル基を有する粒状多
孔質キトサンとした。その後5.0gの無水酢酸を加え一
晩浸潤させ、アミノ基をアセチル化しアルコールを除去
した後、1N-水酸化ナトリウム50mlを加えて1時間湿潤
し中性になる迄洗浄した。この粒状体の活性基密度は35
0μmol/ml粒状体で、これをジオキサン100ml中に懸濁し
た後、ジシクロヘキシルカルボジイミドとN-ヒドロキシ
コハク酸イミドを共に0.1Mになる様に加え一晩浸潤させ
ジオキサンとメチルアルコールで充分洗浄して比表面積
85m2/gの抗体固定化用担体40mlを得た。応用例と同様
にモノクローナル抗ラクトフェリン抗体を固定化させ反
応率を求めたところ16%である。Comparative example Detoxification degree 77%, average molecular weight 42,000 chitosan 65g
Was dissolved in 935 g of a 3.25% acetic acid aqueous solution, and the solution was dropped into a mixed solution of 7% sodium hydroxide, 30% ethanol, and 63% water from a nozzle having a hole diameter of 0.15 mm to coagulate and regenerate the medium. Washed with water until it becomes stable
Granular porous chitosan 0.9 was obtained. 50 ml of the obtained granular porous chitosan (wet state) was added to dimethylformamide 50.
After washing by displacement twice with ml, 50 g of a dimethylformamide solution containing 0.5 g of adipic acid active ester was added and wetted overnight. Then, it was washed 4 times with 50 ml of dimethylformamide, 1.0 g of succinic anhydride was added and allowed to infiltrate overnight, and washed 4 times with methyl alcohol to obtain granular porous chitosan having a carboxyl group. After that, 5.0 g of acetic anhydride was added and allowed to infiltrate overnight, the amino groups were acetylated to remove the alcohol, 50 ml of 1N sodium hydroxide was added, and the mixture was wet for 1 hour and washed until neutral. The active group density of this granular material is 35.
0 μmol / ml granular material, which was suspended in 100 ml of dioxane, added with dicyclohexylcarbodiimide and N-hydroxysuccinimide so that both of them became 0.1 M, and allowed to infiltrate overnight, and washed thoroughly with dioxane and methyl alcohol to obtain a ratio. Surface area
40 ml of an antibody immobilizing carrier of 85 m 2 / g was obtained. The monoclonal anti-lactoferrin antibody was immobilized in the same manner as in the application example, and the reaction rate was determined to be 16%.
この比較例に示した通り、活性基密度が大きいと反応率
が低下してしまい実質的使用に不適となる。As shown in this comparative example, if the density of the active groups is large, the reaction rate is lowered and it becomes substantially unsuitable for use.
[発明の効果] 本発明は、上述の如く多孔質粒状キトサンを予め無水酢
酸でアミノ基の密度を制御し、無水コハク酸でカルボキ
シル基を導入したことにより、活性基密度を5〜140μm
ol/ml粒状体であるように制御することができたため
に、分子量の大きい抗体の固定化に優れた、アフィニテ
ィ−クロマトグラフィー用等に好適な抗体固定化用担体
が得られる効果がある。[Effects of the Invention] The present invention controls the density of amino groups in advance with acetic anhydride in porous granular chitosan as described above, and introduces a carboxyl group with succinic anhydride, thereby making the active group density 5 to 140 μm.
Since it can be controlled to be ol / ml particles, there is an effect that an antibody immobilizing carrier suitable for affinity chromatography, which is excellent in immobilizing an antibody having a large molecular weight, can be obtained.
Claims (1)
チル化した後、無水コハク酸で処理し、更にジシクロヘ
キシルカルボジイミドとN-ヒドロキシスクシンイミドで
処理することを特徴とする抗体固定化用担体の製造法。1. A method for producing a carrier for immobilizing an antibody, which comprises partially acetylating granular porous chitosan with acetic anhydride, then treating with succinic anhydride, and further treating with dicyclohexylcarbodiimide and N-hydroxysuccinimide. .
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP62315734A JPH0662680B2 (en) | 1987-12-14 | 1987-12-14 | Method for producing carrier for immobilizing antibody |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP62315734A JPH0662680B2 (en) | 1987-12-14 | 1987-12-14 | Method for producing carrier for immobilizing antibody |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH01158000A JPH01158000A (en) | 1989-06-21 |
| JPH0662680B2 true JPH0662680B2 (en) | 1994-08-17 |
Family
ID=18068892
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP62315734A Expired - Fee Related JPH0662680B2 (en) | 1987-12-14 | 1987-12-14 | Method for producing carrier for immobilizing antibody |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH0662680B2 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0720984B2 (en) * | 1989-09-22 | 1995-03-08 | 栗田工業株式会社 | How to remove endotoxin |
-
1987
- 1987-12-14 JP JP62315734A patent/JPH0662680B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JPH01158000A (en) | 1989-06-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Cuatrecasas et al. | [31] Affinity chromatography | |
| US5092992A (en) | Polyethyleneimine matrixes for affinity chromatography | |
| US4111838A (en) | Composition for chromatography | |
| US4879340A (en) | Adsorbent composed of porous beads of chitosan and adsorption method using same | |
| JPH0144725B2 (en) | ||
| JP2006300965A (en) | Stable avidin composition and method of use thereof | |
| US5085779A (en) | Polyethyleneimine matrixes for affinity chromatography | |
| EP0621074B1 (en) | Hydrophilic polymer coated perfluorocarbon polymer-based matrices, their preparation and use in bioaffinity separations | |
| KR940005581B1 (en) | Immobilization Method of Enzyme and Immobilized Enzyme | |
| WO2001074420A1 (en) | Adsorbents for high mobility group proteins and column for purifying body fluid | |
| JPH0427504B2 (en) | ||
| US4523997A (en) | Affinity chromatography matrix with built-in reaction indicator | |
| EP0122969B1 (en) | Immobilized oligopeptides | |
| US5096593A (en) | Separation material derived from glucomannan for blood coagulation factor, preparation and use thereof | |
| JPH0662680B2 (en) | Method for producing carrier for immobilizing antibody | |
| CA1332598C (en) | Polyethyleneimine matrixes for affinity chromatography | |
| US4279998A (en) | Regenerable insoluble support for protein immobilization | |
| SU1479511A1 (en) | Method of producing affinic sorbent | |
| CA1063049A (en) | Preparation of water insoluble immobilized bio-active compounds | |
| JPH0718848B2 (en) | Method for manufacturing carrier for affinity chromatography | |
| JPS63258579A (en) | Method for producing carrier for immobilizing physiologically active substances | |
| JPS6348451A (en) | Adsorption carrier for chromatography | |
| Ayhan et al. | Protein A immobilized poly (methylmethacrylate-co-hydroxyethylmethacrylate) microbeads for IgG adsorption | |
| JPS61152634A (en) | Production of immobilized physiologically active substance | |
| JPS6348453A (en) | Carrier for chromatography and its production |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| LAPS | Cancellation because of no payment of annual fees |